Heart Transplantation With Older Donors: Should There Be an Age Cutoff?

Qiudong Chen1, Jon Kobashigawa2, Dominic Emerson1

  • 1Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Insights

Using older donor hearts (≥55 years) for heart transplantation shows similar survival rates but increased nonfatal adverse events in carefully selected recipients. Donor age impacts long-term outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Geriatric Cardiology

Background:

  • Heart transplantation is vital but limited by donor organ availability.
  • The use of older donor hearts (≥55 years) is debated due to potential outcome disparities.
  • Optimizing donor pool utilization is crucial for meeting transplant demand.

Purpose of the Study:

  • To compare heart transplant outcomes between recipients of donor hearts aged ≥55 years and those aged <55 years.
  • To evaluate the impact of donor age on short- and long-term graft survival and adverse events.
  • To assess the viability of utilizing older donor hearts in specific recipient populations.

Main Methods:

  • Retrospective review of first-time adult heart transplant recipients (2010-2019).
  • Analysis of endpoints including 30-day, 1-, 3-, and 5-year survival, freedom from cardiac allograft vasculopathy, and major adverse cardiac events.
  • Statistical analysis using Cox proportional hazards modeling, propensity score matching, and Kaplan-Meier survival analysis.

Main Results:

  • In unmatched cohorts, no significant survival differences were observed at any time point.
  • Recipients of older donor hearts (≥55 years) showed lower freedom from cardiac allograft vasculopathy and fatal major adverse cardiac events.
  • Propensity-matched analysis revealed similar survival and freedom from cardiac allograft vasculopathy, but significantly lower freedom from nonfatal major adverse cardiac events at 1, 3, and 5 years for recipients of older donors.

Conclusions:

  • Carefully selected older donors can be considered for specific recipient groups.
  • Outcomes are acceptable, but careful patient selection is paramount.
  • Increased risk of nonfatal adverse events warrants consideration in recipients of older donor hearts.
Abstract